Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Moe, Okuda"'
Autor:
Seiya Yamayoshi, Mutsumi Ito, Kiyoko Iwatsuki-Horimoto, Atsuhiro Yasuhara, Moe Okuda, Taiki Hamabata, Jurika Murakami, Calvin Duong, Tsukasa Yamamoto, Yudai Kuroda, Ken Maeda, Yoshihiro Kawaoka
Publikováno v:
One Health, Vol 17, Iss , Pp 100588- (2023)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued to circulate in humans since its emergence in 2019. While infection in humans continues, numerous spillover events to at least 32 animal species, including companion and zoo a
Externí odkaz:
https://doaj.org/article/31f2abccbea2450c8140051f92ab1d78
Autor:
Atsuhiro Yasuhara, Seiya Yamayoshi, Maki Kiso, Yuko Sakai-Tagawa, Moe Okuda, Yoshihiro Kawaoka
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Broadly protective antibodies targeting influenza viruses are of interest as potential therapeutics or to inform vaccine development. Here the authors characterize a human mAb (DA03E17) with heterosubtypic binding to neuraminidases from IAVs and IBVs
Externí odkaz:
https://doaj.org/article/60235b0ade9148b3bc6980e15ec99ce4
Autor:
Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Moe Okuda, Michiko Ujie, Atsuhiro Yasuhara, Jurika Murakami, Calvin Duong, Taiki Hamabata, Mutsumi Ito, Shiho Chiba, Ryo Kobayashi, Satoshi Takahashi, Keiko Mitamura, Masao Hagihara, Akimichi Shibata, Yoshifumi Uwamino, Naoki Hasegawa, Toshiaki Ebina, Akihiko Izumi, Hideaki Kato, Hideaki Nakajima, Norio Sugaya, Yuki Seki, Asef Iqbal, Isamu Kamimaki, Masahiko Yamazaki, Yoshihiro Kawaoka, Yuki Furuse
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 11, Pp 2198-2205 (2022)
Japan has reported a relatively small number of COVID-19 cases. Because not all infected persons receive diagnostic tests for COVID-19, the reported number must be lower than the actual number of infections. We assessed SARS-CoV-2 seroprevalence by a
Externí odkaz:
https://doaj.org/article/9adaa9f3408440039258cdaea67161f0
Autor:
Shinya Yamamoto, Seiya Yamayoshi, Mutsumi Ito, Yuko Sakai-Tagawa, Ichiro Nakachi, Rie Baba, Shigenobu Kamimoto, Takayuki Ogura, Shigehiro Hagiwara, Hideaki Kato, Hideaki Nakajima, Yoshifumi Uwamino, Kazuma Yagi, Norio Sugaya, Hiroyuki Nagai, Makoto Saito, Eisuke Adachi, Michiko Koga, Takeya Tsutsumi, Calvin Duong, Moe Okuda, Jurika Murakami, Yuri Furusawa, Michiko Ujie, Kiyoko Iwatsuki-Horimoto, Hiroshi Yotsuyanagi, Yoshihiro Kawaoka
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107208- (2023)
Summary: SARS-CoV-2 has gradually acquired amino acid substitutions in its S protein that reduce the potency of neutralizing antibodies, leading to decreased vaccine efficacy. Here, we attempted to obtain mutant viruses by passaging SARS-CoV-2 in the
Externí odkaz:
https://doaj.org/article/517adb32d19c447b88d368466fbef197
Autor:
Kiyoko Iwatsuki-Horimoto, Mutsumi Ito, Moe Okuda-Hamabata, Hisayoshi Takagi, Masaki Imai, Yoshihiro Kawaoka
Publikováno v:
Viruses, Vol 15, Iss 12, p 2280 (2023)
Cardiovascular disease is one of many risk factors that have been linked to increased severity or mortality in coronavirus disease 2019 (COVID-19) patients; however, the exact role of SARS-CoV-2 in the pathogenesis of cardiac inflammatory injury has
Externí odkaz:
https://doaj.org/article/35bedbc2a93442418fdee8199a400423
Autor:
Shiho Chiba, Maki Kiso, Noriko Nakajima, Shun Iida, Tadashi Maemura, Makoto Kuroda, Yuko Sato, Mutsumi Ito, Moe Okuda, Shinya Yamada, Kiyoko Iwatsuki-Horimoto, Tokiko Watanabe, Masaki Imai, Tammy Armbrust, Ralph S. Baric, Peter J. Halfmann, Tadaki Suzuki, Yoshihiro Kawaoka
Publikováno v:
mBio, Vol 13, Iss 1 (2022)
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide since December 2019, causing coronavirus disease 2019 (COVID-19). Although vaccines for this virus have been developed rapidly, repurposing drugs approved to t
Externí odkaz:
https://doaj.org/article/b06f8d8ad736460ead83f0867cc3f591
Autor:
Ryuta Uraki, Masaki Imai, Mutsumi Ito, Hiroaki Shime, Mizuyu Odanaka, Moe Okuda, Yoshihiro Kawaoka, Sayuri Yamazaki
Publikováno v:
PLoS Pathogens, Vol 17, Iss 12 (2021)
Regulatory T (Treg) cells, which constitute about 5–10% of CD4+T cells expressing Foxp3 transcription factor and CD25(IL-2 receptor α chain), are key regulators in controlling immunological self-tolerance and various immune responses. However, how
Externí odkaz:
https://doaj.org/article/f4df4eb45c6e4305bb458da893fc2b7f
Autor:
Seiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, Osamu Akasaka, Morio Nakamura, Ichiro Nakachi, Michiko Koga, Keiko Mitamura, Kazuma Yagi, Kenji Maeda, Hideaki Kato, Masanori Nojima, David Pattinson, Takayuki Ogura, Rie Baba, Kensuke Fujita, Hiroyuki Nagai, Shinya Yamamoto, Makoto Saito, Eisuke Adachi, Junichi Ochi, Shin-ichiro Hattori, Tetsuya Suzuki, Yusuke Miyazato, Shiho Chiba, Moe Okuda, Jurika Murakami, Taiki Hamabata, Kiyoko Iwatsuki-Horimoto, Hideaki Nakajima, Hiroaki Mitsuya, Norio Omagari, Norio Sugaya, Hiroshi Yotsuyanagi, Yoshihiro Kawaoka
Publikováno v:
EClinicalMedicine, Vol 32, Iss , Pp 100734- (2021)
Background: To develop an effective vaccine against a novel viral pathogen, it is important to understand the longitudinal antibody responses against its first infection. Here we performed a longitudinal study of antibody responses against SARS-CoV-2
Externí odkaz:
https://doaj.org/article/93fc7a3385ff4a548da167956b32908b
Autor:
Takayuki, Fujii, Masao, Hagihara, Keiko, Mitamura, Shiori, Nakashima, Shin, Ohara, Tomoyuki, Uchida, Morihiro, Inoue, Moe, Okuda, Atsuhiro, Yasuhara, Jurika, Murakami, Calvin, Duong, Kiyoko, Iwatsuki-Horimoto, Seiya, Yamayoshi, Yoshihiro, Kawaoka
Publikováno v:
Internal Medicine. 61:1681-1686
Objective Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally. Although the relationship between anti-SARS-CoV-2 immunoglobulin G (IgG) antibodies and COVID-19 severity has been
Autor:
Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Moe Okuda, Michiko Ujie, Atsuhiro Yasuhara, Jurika Murakami, Calvin Duong, Taiki Hamabata, Mutsumi Ito, Shiho Chiba, Ryo Kobayashi, Satoshi Takahashi, Keiko Mitamura, Masao Hagihara, Akimichi Shibata, Yoshifumi Uwamino, Naoki Hasegawa, Toshiaki Ebina, Akihiko Izumi, Hideaki Kato, Hideaki Nakajima, Norio Sugaya, Yuki Seki, Asef Iqbal, Isamu Kamimaki, Masahiko Yamazaki, Yoshihiro Kawaoka, Yuki Furuse
Japan has reported a small number of COVID-19 cases relative to other countries. Because not all infected people receive diagnostic tests for COVID-19, the reported number of COVID-19 cases must be lower than the actual number of infections. Assessme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::416e5f9653819546f0fdfde6ec2dd47c
https://doi.org/10.1101/2022.07.11.22277481
https://doi.org/10.1101/2022.07.11.22277481